MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Understanding, predicting, and preventing falls in progressive supranuclear palsy

    B.R. Bluett, I. Litvan, S. Cheng, J. Juncos, Y. Bordelon, D.E. Riley, D. Standaert, S.G. Reich, D.A. Hall, B. Kluger, D. Shprecher, C. Marras, J. Jankovic (Las Vegas, NV, USA)

    Objective: To (1) evaluate which factors are associated with increasing falls in Progressive Supranuclear Palsy (PSP), unrelated to freezing; and (2) subsequently develop a predictive…
  • 2016 International Congress

    Parkinsonism and movement disorders in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

    I. Amorín, A. Lescano, A. Panuncio, V. Raggio, R. Buzó (Montevideo, Uruguay)

    Objective: To study and report the frequency of movement disorders in Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). Background: CADASIL is the main…
  • 2016 International Congress

    Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease

    M. Sanoeva, N. Mansurova, A. Prokhorova (Bukhara, Uzbekistan)

    Objective: To evaluate hyposmia as a predictor of non-motor features in patients with early Parkinson's disease (PD). Background: Hyposmia is quite a common finding in…
  • 2016 International Congress

    Body weight determinants in Parkinson’s disease: A multifactorial study

    A. Bril, M. Rossi, S. Fariña, P. Morisset, L. Sorrentino, M. Iglesias, A. Medina Escobar, P. Millar Vernetti, D. Cerquetti, S. Perez Lloret, M. Merello (Buenos Aires, Argentina)

    Objective: The aim of this study was to investigate the relationship between some of the variables that may influence body weight and the observed body…
  • 2016 International Congress

    Depression and anxiety in Parkinson’s disease with rapid eye movement sleep behavior disorder

    Y. Saitoh, Y. Mukai, T. Sakamoto, M. Murata (Tokyo, Japan)

    Objective: To investigate whether rapid eye movement sleep behavior disorder (RBD) is associated with depression or anxiety in patients with Parkinson's disease (PD). Background: RBD…
  • 2016 International Congress

    The non-motor side of the honey-moon period of Parkinson’s disease

    R. Erro, M. Picillo, C. Vitale, M. Amboni, M. Moccia, M.T. Pellecchia, P. Barone (London, United Kingdom)

    Objective: To explore the non-motor side of the honey-moon period in Parkinson's disease (PD) and its impact on quality of life (QoL). Background: Although there…
  • 2016 International Congress

    P100 latency of pattern reversal visual evoked potential and visual hallucination in Parkinson’s disease

    M. Kohsaka, T. Oeda, A. Umemura, S. Tomita, K. Park, K. Yamamoto, H. Sugiyama, H. Sawada (Kyoto, Japan)

    Objective: To investigate whether P100 latency of pattern reversal visual evoked potential (PR-VEP) can predict the development of visual hallucination (VH) in Parkinson's disease (PD).…
  • 2016 International Congress

    Impulse control disorders after STN DBS for Parkinson’s disease

    P.G. Frederic, P. Camille, J. Nicolas, S. Abbas, F. Maria, P. Michel (Montreal, QC, Canada)

    Objective: To evaluate the prevalence and severity of impulse control disorders (ICD) and other impulsive-compulsive behaviors (ICB) in a cohort of patients with Parkinson's disease…
  • 2016 International Congress

    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease. PPMI cohort

    T. Simuni, D. Weintraub, C. Caspell-Garcia, M. Walker, C.S. Coffey, S. Lasch, C. Tanner, D. Jennings, K. Kieburtz, K. Marek, On behalf of the PPMI Investigators (Chicago, IL, USA)

    Objective: To examine baseline prevalence and longitudinal change in non-motor symptoms (NMS) in a cohort of de novo (at baseline) Parkinson's disease (PD) patients compared…
  • 2016 International Congress

    Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease

    J.F. Pascacio-Astudillo, A.L. Bazàn-Rodrìguez, M. Rodrìguez-Violante, A. Cervantes-Arriaga (Mèxico City, Mexico)

    Objective: To determine the prevalence of neuropathic pain in PD and association between neuropathic pain, duration of PD, treatment with Levodopa, cumulative dose, non-motor symptoms…
  • « Previous Page
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley